Menu Close

Parallel Session: Mucositis – New Dimensions in Research and Clinical Practice



Dr Sharon Elad
Professor and Chair, Division of Oral Medicine
Principal Consultant, Hospital Dentistry
Eastman Institute for Oral Health
University of Rochester Medical Center
Session Chair

Dr Hannah Wardill
NHMRC CJ Martin Biomedical Research Fellow, Supportive Oncology Research Group, South Australian Health and Medical Research Institute (SAHMRI), Adelaide Medical School, University of Adelaide, Australia

Dr Margie Shaw
Assistant Professor and Director of the Law and Bioethics Theme, University of Rochester School of Medicine and Dentistry, USA

Dr Rajesh Lalla
Professor (with tenure), Associate Dean for Research, School of Dental Medicine, University of Connecticut Health Center, USA

Dr Andrew Mazar
Chief Scientific Officer, Research and Development, Monopar Therapeutics, USA

Dr Elisa Kauark-Fontes
Dentist (DDS), Oral Diagnosis Department, Faculdade de Odontologia de Piracicaba (FOP/UNICAMP), Piracicaba/São Paulo, Brazil

Dr Charlotte de Mooij
Department of Hematology, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands


  • The Complexity of Predicting Mucositis with Dr Hannah Wardill
  • Bioethical Considerations Related to Mucositis Research and Management with Dr Margie Shaw
  • Oral Proffered Paper 1: Efficacy And Safety Of Dentoxol In The Prevention Of Radiation-Induced Oral Mucositis In Head And Neck Cancer Patients with Dr Rajesh Lalla
  • Oral Proffered Paper 2: Subgroup Analysis of Head and Neck Cancer Patients Treated with Clonidine Mucobuccal Tablet in a Randomized, Double-Blind Phase 2 Trial (Study BA2009-28-01) Supports Further Clinical Development in Patients with Oropharyngeal Cancer with Dr Andrew Mazar
  • Oral Proffered Paper 3: Extraoral Photobiomodulation Therapy for Oral Mucositis in Oral and Oropharyngeal Cancer Patients: Interim Analysis of a Randomized Clinical Trial with Dr Elisa Kauark-Fontes
  • Oral Proffered Paper 4: Grading Bloodstream Infection Risk Using Citrulline as Biomarker of Intestinal Mucositis in Hemato-Oncology Patients with Dr Charlotte de Mooij

Disclaimer: The views and opinions of presenters do not necessarily reflect those of MASCC or ISOO.